☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Biogen
Biogen’s Qalsody (tofersen) Receives CHMP’s Positive Opinion for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
February 23, 2024
Biogen Receives the European Commission’s Approval for Skyclarys (omaveloxolone) to Treat Friedreich’s Ataxia (FA)
February 14, 2024
Kathleen Somera-Molina, Head of SMA Global Medical Affairs at Biogen Shares Insights on New SPINRAZA (nusinersen) Long-Term Data i...
August 7, 2023
Biogen and Sage Therapeutics’ Zurzuvae (zuranolone) Receive the US FDA’s Approval for Women with Postpartum Depression
August 7, 2023
PharmaShots Weekly Snapshots (July 31 – August 04, 2023)
August 4, 2023
Biogen to Acquire Reata Pharmaceuticals for ~$7.3B
July 31, 2023
Load more...
Back to Home